Skip to main content
Tech.euFundingExplorerBeta

Kerecis

Kerecis produces medical products made from intact fish skin used to treat burns and complex acute and chronic wounds.

Kerecis has raised €131M across 3 funding rounds from 5 investors, most recently a Series D+ round in Jul 2022. Based in Ísafjörður, Iceland; founded 2010; active in Healthtech. Data as of 28 Oct 2026.

Ísafjörður, IcelandFounded 2010www.kerecis.com ↗
Total raised
€131M
€130,593,523
Funding rounds
3
Investors
5
distinct backers
Active since
2019-04
latest 2022-07

Funding by year

EUR raised per year
Kerecis — funding by year — interactive chart.
Data table
Kerecis — funding by year
2019€14M
2020€18M
2022€99M

Signals

High confidence
Raise-next likelihood11
base rate 53% for Series D+
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▼ Old (16y) — past typical exit age
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2022-07-27Series D+€99MBRU,Emerson Collective,KIRKBI,LSVView deal →
2020-08-05Debt€18MSilicon Valley BankView deal →
2019-04-01Series C€14M—View deal →

Similar companies

same sector or country

Global coverage: FundingData